Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indopoly Swakarsa Industry Tbk (IPOL) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Indopoly Swakarsa Industry TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Indopoly Swakarsa Industry Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Indopoly Swakarsa Industry Tbk trades at Rp113 (market cap 728.1B, 439.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp161 (market cap 635.95B, 288.1K 24h volume). The key difference: Indopoly Swakarsa Industry Tbk and UBC Medical Indonesia Tbk. are close in size by market cap, and Indopoly Swakarsa Industry Tbk is more actively traded (439.5K versus 288.1K). Which is the better fit depends on your goals.

IPOLLABS
Market Cap
728.1B635.95B
Volume
439.5K288.1K
Lot
4.4K2.88K
Turnover
50.14M46.81M
Average Price
114.08162.49
Value
50.14M46.81M
Indicative Equilibrium Price
113163
Indicative Equilibrium Volume
1.1K16

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IPOL
View details
LABS
View details

About Indopoly Swakarsa Industry Tbk

PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.

Read more on IPOL

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS